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• Melanoma is one of three types of skin 
cancer, predominately caused by exposure 
to UV radiation.1 Previous studies indicate 
that melanomas have a high tumor 
mutation burden (TMB), promoting 
immunogenicity and signif icant anti-tumor 
immune responses due to the translation of 
mutations into neoantigens.1,2
• Neoantigen-containing tumors are know n to 
be responsive to immunotherapies3, 
how ever, many do not respond to such 
treatments. It is unclear w hat differentiates 
responding tumors from non-responders.
• New  high TMB melanoma cell models that 
could be studied in immunocompetent mice 
w ould be beneficial to help understand anti-
melanoma immune responses.
• We hypothesize that expanding the TM B 
of melanoma cells by irradiation with 
UV-A and UV-B will increase 
immunogenicity and inhibit tumor 
growth in immunocompetent mice.
• We tested our hypothesis using the 
follow ing specif ic aims:
➢ Irradiate cell lines YUMM 5.2 and B16-F0 
w ith solar-simulating UVA/B radiation. 
➢ Perform DNA sequencing  to determine the 
effect of the UV treatments on the cells’ 
TMB.
➢ Evaluate in vitro cell grow th and in vivo 
tumor grow th of the high TMB cells in 
immunocompetent mice. 
➢ Evaluate cellular energetics and antigenic 
responses of the high TMB cells.  
Bioenergetics in Parental and Irradiated Cell Lines
Five Day Cell Growth 
Analysis
T-cell Tumor Killing Assay 

















































































































• We successfully generated high TMB clones of B16 
and YUMM5.2
• In vitro cell grow th assay show s a small decrease of 
cell grow th in the high TMB B16 cells compared to 
parental cells. 
• In vivo tumor grow th data show s that the UV treated
B16 cell line has faster grow th.
• T cell tumor killing assay show s activated T cells 
induce signif icantly higher rate of apoptosis in the high 
TMB B16 clone versus parental.  
• Seahorse mito stress test show s that high TMB clones 
have differentially altered cellular bioenergetics 
compared to parental cells. 
• FACS analysis of the tumor and spleen indicate that a 
high TMB recruits a greater number of immune cells. 
• UV Treatments: Cell lines B16 and genetically 
engineered YUMM 5.2 w ere irradiated three times at 
intensities that generate severe skin burns at time 
intervals of 52.5 seconds, 1:45 minutes, 3:30 minutes 
and 7:00 minutes.  After the three rounds of 
treatments, surviving clones w ere selected and 
seeded.
• Whole Exome Sequencing (WES): DNA w as 
extracted from UV treated and parental cell lines using 
QIAamp DNA Mini Kit (250), quantif ied and WES w as 
performed.
• Seahorse Assay: Parental and UV treated cells w ere 
plated in Seahorse assay plates and mito-stress test 
w as performed follow ing the manufacturer’s 
instructions.
• Cytotoxic T-cell tumor killing assay: DDAO-labeled
tumor cells w ere seeded in 96 w ell plates and co-
cultured w ith IL2-activated T Cells from Black 6 mice 
for 3 hours, and apoptosis induction in tumor cells w as 
detected using FACS analysis for cleaved Caspase 3.   
• Cell growth and tumor growth studies: Parental B16 
and UV-treated cells w ere seeded in 96 w ell plates and 
cell grow th over a period of 5 days w as evaluated 
using Cell Titer Blue. Parental B16 and UV treated cell 
line, B16 3:30 Clone 3, w ere implanted into mice at a 
concentration of 3x105 cells per injection. After the 
implantations, tumor progression/regression after one 
w eek w as evaluated. 
• MDACC University Outreach 
• Melanoma Medical Oncology Dept.
➢ Wanleng Deng, Alice Liu
• Dr. Eric Peden for helping w ith fabrication of the UVA/B light box
Figure 5. Oxygen Consumption Rate (OCR) and Extracellular Acidification Rate (ECAR) were measured in the indicated cell lines .
Figure 1. 
Parental and UV 
treated cell lines
were assessed 
in triplicates for 
a f iv e-day cell 
growth assay . 
Figure 4. B16 and B16 UV Cl3 apoptotic rates were 
ev aluated by caspase 3 cleavage. 
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Figure 3: Percentage of different types of tumor-infiltrating cells. 
Figure 2. Sub-cutaneous tumor growth of B16 
parental and B16.UV.Cl3 cells in B6 mice.  





UVA/B-induced TMB in B16 and YUMM5.2 cells 





























YUMM5.2 UVR Clones & UVR 
Exposure Times 
# of New 
Mutations
YUMM5.2 Clone 1.1 : 52.5sec 2218
YUMM5.2 Clone 1.2 : 52.5 sec 2681
YUMM5.2 Clone 1.3 : 52.5sec 2549
YUMM5.2 Clone 2 : 1:45 min 2955
B16-F0 UVR Clones & UVR 
Exposure Times
# of New 
Mutations
B16 Clone 1.1 : 52.5 sec 1758
B16 Clone 1.2: 52.5 sec 1420
B16 Clone 2 : 1:45 min 1471
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Figure 6. UV treatment procedure
